STOCK TITAN

Celestica (NYSE: CLS) insider plans NYSE sale of 87,368 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Celestica Inc. insider Yann L. Etienvre has filed to sell 87,368 common shares of the company on the NYSE. The planned sales include 86,226 shares around 02/02/2026 and 1,142 shares around 02/04/2026 through broker Canaccord Genuity.

The shares to be sold were recently acquired via performance and restricted share unit vesting from Celestica on 02/02/2026 and 02/04/2026. Etienvre also sold 9,187 common shares on 12/01/2025 for disclosed gross proceeds, indicating ongoing liquidity activity in Celestica stock.

Positive

  • None.

Negative

  • None.

Insights

Insider Form 144 shows planned sales of recently vested Celestica stock.

The notice shows Yann L. Etienvre planning to sell 87,368 Celestica common shares on the NYSE via Canaccord Genuity. The filing lists two planned blocks: 86,226 shares with aggregate market value of 24228643.74 and 1,142 shares valued at 320890.58.

The shares come from recent equity compensation. On 02/02/2026, 82,702 common shares vested from performance share units and 3,524 from restricted share units, and on 02/04/2026 another 1,142 vested from restricted share units. The form also notes a prior sale of 9,187 common shares on 12/01/2025 with gross proceeds of 2970892.06.

The signer represents they do not know any undisclosed material adverse information about Celestica’s current or prospective operations. The actual impact on ownership and trading will depend on execution of these planned sales and broader market conditions, which are not detailed here.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for Celestica (CLS) disclose?

The filing discloses planned sales of Celestica common shares by insider Yann L. Etienvre. It details two NYSE transactions via Canaccord Genuity totaling 87,368 shares, along with acquisition dates, vesting sources, and a prior sale in December 2025 with stated gross proceeds.

How many Celestica (CLS) shares does Yann L. Etienvre plan to sell?

Etienvre plans to sell a total of 87,368 Celestica common shares. The notice lists 86,226 shares with an aggregate market value of 24,228,643.74 and an additional 1,142 shares valued at 320,890.58, all to be sold on the NYSE through Canaccord Genuity.

When are the planned Celestica (CLS) share sales expected to occur?

The planned Celestica share sales are targeted for early February 2026. The Form 144 specifies an approximate sale date of February 2, 2026 for 86,226 shares and February 4, 2026 for 1,142 shares, both through Canaccord Genuity on the NYSE.

How did Yann L. Etienvre acquire the Celestica (CLS) shares being sold?

The shares came from performance and restricted share unit vesting at Celestica. On February 2, 2026, 82,702 common shares vested from performance share units and 3,524 from restricted share units, with a further 1,142 restricted share units vesting on February 4, 2026.

Has Yann L. Etienvre recently sold other Celestica (CLS) shares?

Yes, Etienvre previously sold 9,187 Celestica common shares. The filing reports a sale on December 1, 2025 of 9,187 shares, producing gross proceeds of 2,970,892.06, which is separate from the newly planned transactions disclosed in this notice.

What representation does the seller make about Celestica (CLS) in this Form 144?

The seller represents not knowing any undisclosed material adverse information about Celestica. By signing the notice, the person states they are unaware of non-public negative information about Celestica’s current or prospective operations related to the securities being sold.